Oliver J. Mcelvaney

Intensive Care Medicine | Pulmonary Medicine

University Of Washington Medical Center
1959 Ne Pacific Street
Seattle, WA 98195

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Forced vital capacity in pulmonary exacerbations of cystic fibrosis.

Forced vital capacity in pulmonary exacerbations of cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 11, 2026

A state of the union on alpha-1 antitrypsin deficiency at the Veterans Health Administration.

A state of the union on alpha-1 antitrypsin deficiency at the Veterans Health Administration.

Journal: Annals of the American Thoracic Society

Published: November 23, 2025

An alternative view of changes in lung function among people with cystic fibrosis.

An alternative view of changes in lung function among people with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 11, 2025

Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes.

Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 22, 2025

Representation of Minoritized People with Cystic Fibrosis in CF Therapeutics Development Network Clinical Trials.

Representation of Minoritized People with Cystic Fibrosis in CF Therapeutics Development Network Clinical Trials.

Journal: Annals of the American Thoracic Society

Published: July 21, 2025

Further Insights into Emphysema Progression and Lung Function Decline in MZ Alpha-1 Antitrypsin Deficiency.

Further Insights into Emphysema Progression and Lung Function Decline in MZ Alpha-1 Antitrypsin Deficiency.

Journal: Annals of the American Thoracic Society

Published: June 04, 2025

Rationale and Design of the Alpha-1 Biomarkers Consortium Study.

Rationale and Design of the Alpha-1 Biomarkers Consortium Study.

Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)

Published: April 24, 2025

Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US.

Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 17, 2025

International Medical Graduates and the Physician Workforce.

International Medical Graduates and the Physician Workforce.

Journal: JAMA

Published: July 15, 2024

Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators.

Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators.

Journal: BMC pulmonary medicine

Published: February 22, 2024

Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.

Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.

Journal: Annals of the American Thoracic Society

Published: December 14, 2023

Undiagnosed Alpha-1 Antitrypsin Deficiency and the Perpetuation of Lung Health Inequity.

Undiagnosed Alpha-1 Antitrypsin Deficiency and the Perpetuation of Lung Health Inequity.

Journal: American journal of respiratory and critical care medicine

Published: October 25, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026